The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects-Reference-Cited by-同舟云学术

The Body weight Reducing Effects of Tirzepatide in People with and without Type 2 Diabetes: A Review on Efficacy and Adverse Effects

Published:2024-02 Issue: Volume:Volume 18 Page:373-382
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Jensen Thomas Leth^ORCID,Brønden Andreas,Karstoft Kristian,Sonne David,Christensen Mikkel

Publisher

Informa UK Limited

Reference56 articles.

1. World Obesity Federation. World Obesity Atlas 2023; 2023. Available from: https://data.worldobesity.org/publications/?cat=19. Accessed July 24, 2023.

2. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

3. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study

4. The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

5. The Role of Incretins on Insulin Function and Glucose Homeostasis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies;Diseases;2024-09-05

2. The effectiveness and sustainability of health outcomes from a holistic digital weight‐loss service with concomitant initiation of tirzepatide: A pragmatic randomized controlled trial in the UK;Diabetes, Obesity and Metabolism;2024-09-02

3. Bone Fragility in Diabetes and its Management: A Narrative Review;Drugs;2024-08-05

4. Effect of tirzepatide on leptin and adiponectin levels;European Journal of Internal Medicine;2024-08

5. The impact of approved anti-obesity medications on osteoarthritis;Expert Opinion on Pharmacotherapy;2024-07-23